One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The label mirror assumes little dialysis removal. The 2018 study measured bisoprolol removal with high-flux dialysis, so the dialysis technology and evidence era matter.
What to reconcile: This small PK study does not validate a replacement dose or outcome benefit. Reconcile dialysis method, dose timing, blood pressure and pulse with the treating team; do not calculate a supplement from a clearance number.
Open this note and its source referencesThis randomized, open-label four-way crossover pharmacokinetic study enrolled eight hemodialysis patients and tested single beta-blocker doses. Bisoprolol clearance by the recovery method was 44 mL/min, contradicting the older assumption that it is not dialyzable. The reported observation concerns high-flux hemodialysis; it does not establish a replacement dose, optimal treatment timing, or clinical-outcome benefit. Reconcile the actual dialysis technique and response rather than computing a supplement from clearance alone.
RDM37-professional-bisoprolol-zebeta-0292d9a5c9-C1 · Source locator: Indexed primary-study abstract/methods/results; full-page access blocked on this retrieval.
Primary indexed excerpts read (PMID 29519953; DOI 10.2215/CJN.07470717). PMC full-page retrieval was challenged and publisher retrieval required payment. Not a full-text re-review.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=bisoprolol-zebeta&s1=RDM37-professional-bisoprolol-zebeta-0292d9a5c9&h1=9376a51b06f5b4d4dd7618e8e0e698d000881854808f749d4638cbe03cf2e269